title: [Pulmonary embolism in course of deep vein thrombosis of lower extremities in patient wit bilateral femoral bone fracture after car accident injuries].
abstract: The incidence of deep vein thrombosis in Western World is estimated at about 1 case/1000/year and of pulmonary embolism at 0.5 case/1000/year. Mortality in untreated pulmonary embolism is 30%. With adequate treatment (anticoagulation) it can be decreased to 2-8%. Deep vein thrombosis and pulmonary embolism are frequent complications of various surgical procedures, especially of orthopedic interventions on hip joint. When surgery has to be performed in patient with high risk of pulmonary embolism, anticoagulant prophylaxis should be performed. Venous thromboembolic disease is the most important cause of mortality in trauma patients. We present a case of 46 years old man with bilateral fracture of femoral bone after car accident injury in whom signs of deep venous thrombosis and pulmonary embolism were observed despite the use of anticoagulant prophylaxis.
authors.affiliation: Klinika Chorób Wewnetrznych Klatki Piersiowej Instytutu Gruźlicy i Chorób Płuc w Warszawie.
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Lewandowski
authors.forename: Monika
authors.initials: M
authors.lastname: Szturmowicz
authors.forename: Anna
authors.initials: A
authors.lastname: Fijałkowska
authors.forename: Marcin
authors.initials: M
authors.lastname: Kurzyna
authors.forename: Bogdan
authors.initials: B
authors.lastname: Hajduk
authors.forename: Barbara
authors.initials: B
authors.lastname: Burakowska
authors.forename: Dariusz
authors.initials: D
authors.lastname: Chmielewski
authors.forename: Adam
authors.initials: A
authors.lastname: Torbicki
mesh_terms: D000063:Accidents, Traffic; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage; D001336:Automobiles; D005264:Femoral Fractures / Q000150:complications* / Q000209:etiology / Q000601:surgery*; D005268:Femoral Vein / Q000503:physiopathology; D005593:Fracture Fixation, Internal / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage; D006801:Humans; D008297:Male; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D013997:Time Factors; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000150:complications* / Q000188:drug therapy / Q000209:etiology
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight